Joel W. Slaton

7.6k total citations
118 papers, 6.0k citations indexed

About

Joel W. Slaton is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joel W. Slaton has authored 118 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Surgery, 39 papers in Molecular Biology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joel W. Slaton's work include Bladder and Urothelial Cancer Treatments (32 papers), Renal cell carcinoma treatment (16 papers) and Angiogenesis and VEGF in Cancer (12 papers). Joel W. Slaton is often cited by papers focused on Bladder and Urothelial Cancer Treatments (32 papers), Renal cell carcinoma treatment (16 papers) and Angiogenesis and VEGF in Cancer (12 papers). Joel W. Slaton collaborates with scholars based in United States, Japan and Australia. Joel W. Slaton's co-authors include Colin P. Dinney, Gretchen M. Unger, Khalil Ahmed, Keiji Inoue, David A. Swanson, Curtis A. Pettaway, Paul Perrotte, David A. Levy, Guixia Wang and Kashif Ahmad and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Analytical Chemistry.

In The Last Decade

Joel W. Slaton

114 papers receiving 5.8k citations

Peers

Joel W. Slaton

SURGE

PRM

ONCOL

Yoshiyuki Kakehi Japan

Masaru Murai Japan

Louis Lacombe Canada

Ganesh S. Palapattu United States

Cheol Kwak South Korea

J. Edson Pontes United States

Sten Nilsson Sweden

Toshiyuki Kamoto Japan

Sam S. Chang United States

Syed A. Hussain United Kingdom

Yoshiyuki Kakehi Japan

Joel W. Slaton

2.7k ×1.1

1.9k ×1.0

SURGE

2.7k ×1.6

PRM

1.6k ×1.0

ONCOL

805 ×0.9

Citations per year, relative to Joel W. Slaton Joel W. Slaton (= 1×) peers Yoshiyuki Kakehi

Countries citing papers authored by Joel W. Slaton

Since Specialization

Citations

This map shows the geographic impact of Joel W. Slaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel W. Slaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel W. Slaton more than expected).

Fields of papers citing papers by Joel W. Slaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel W. Slaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel W. Slaton. The network helps show where Joel W. Slaton may publish in the future.

Co-authorship network of co-authors of Joel W. Slaton

This figure shows the co-authorship network connecting the top 25 collaborators of Joel W. Slaton. A scholar is included among the top collaborators of Joel W. Slaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel W. Slaton. Joel W. Slaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sung, Hyun Hwan, Douglas S. Scherr, Joel W. Slaton, et al.. (2021). Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer. Urologic Oncology Seminars and Original Investigations. 39(7). 434.e23–434.e29. 8 indexed citations

Davis, Carole, Paul Hauser, Robert E. Hurst, et al.. (2017). Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancer. Nanotechnology. 29(3). 35101–35101. 43 indexed citations

Lee, Cheryl T., Sam S. Chang, Ashish M. Kamat, et al.. (2014). Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial. European Urology. 66(2). 265–272. 151 indexed citations

Trembley, Janeen H., Gretchen M. Unger, Vicci L. Korman, et al.. (2014). Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice. PLoS ONE. 9(10). e109970–e109970. 16 indexed citations

Trembley, Janeen H., Gretchen M. Unger, Vicci L. Korman, et al.. (2011). Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α′ subunits reduces orthotopic xenograft prostate tumors in mice. Molecular and Cellular Biochemistry. 356(1-2). 21–35. 33 indexed citations

Wenner, Cynthia A., et al.. (2010). Role for toll-like receptor 4 in TNF-alpha secretion by murine macrophages in response to polysaccharide Krestin, a Trametes versicolor mushroom extract. Fitoterapia. 81(7). 914–919. 32 indexed citations

Wang, Xing, Michael J. Wilson, Joel W. Slaton, et al.. (2009). Increased Aggressiveness of Human Prostate PC‐3 Tumor Cells Expressing Cell Surface Localized Membrane Type‐1 Matrix Metalloproteinase (MT1‐MMP). Journal of Andrology. 30(3). 259–274. 28 indexed citations

Trembley, Janeen H., et al.. (2009). Protein Kinase CK2 in Health and Disease. Cellular and Molecular Life Sciences. 66(11-12). 1858–1867. 302 indexed citations

Sloper, Daniel T., et al.. (2008). WL-276, an Antagonist against Bcl-2 Proteins, Overcomes Drug Resistance and Suppresses Prostate Tumor Growth. Cancer Research. 68(11). 4377–4383. 33 indexed citations

10.

Hamilton‐Reeves, Jill, Salome A. Rebello, William Thomas, Joel W. Slaton, & Mindy S. Kurzer. (2007). Soy Protein Isolate Increases Urinary Estrogens and the Ratio of 2:16α-Hydroxyestrone in Men at High Risk of Prostate Cancer ,. Journal of Nutrition. 137(10). 2258–2263. 18 indexed citations

11.

Canales, Benjamin K., Derek Weiland, Joel W. Slaton, et al.. (2006). Angiomyofibroblastoma‐like tumors (cellular angiofibroma). International Journal of Urology. 13(2). 177–179. 29 indexed citations

12.

Wang, Guixia, Gretchen M. Unger, Kashif Ahmad, Joel W. Slaton, & Khalil Ahmed. (2005). Downregulation of CK2 induces apoptosis in cancer cells – A potential approach to cancer therapy. Molecular and Cellular Biochemistry. 274(1-2). 77–84. 95 indexed citations

13.

Kamat, Ashish M., et al.. (2004). Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology. 63(1). 46–50. 82 indexed citations

14.

Rosser, Charles J., Joel W. Slaton, Jonathan I. Izawa, Larry B. Levy, & Colin P. Dinney. (2003). Clinical presentation and outcome of high-grade urinary bladder leiomyosarcoma in adults. Urology. 61(6). 1151–1155. 38 indexed citations

15.

Karashima, Takashi, Keiji Inoue, Taro Shuin, et al.. (2001). Inhibition of angiogenesis by interferon-alpha in human transitional cell carcinoma growing orthotopically in nude mice and study of combination therapy with cytoreductive chemotherapy. 63(4). 223–227. 1 indexed citations

16.

Slaton, Joel W., Takashi Karashima, Paul Perrotte, et al.. (2001). Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.. PubMed. 7(9). 2840–53. 50 indexed citations

17.

Slaton, Joel W., William F. Benedict, & Colin P. Dinney. (2001). p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. Urology. 57(5). 852–859. 40 indexed citations

18.

Slaton, Joel W., David A. Levy, Louis L. Pisters, et al.. (1997). Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinoma. Urology. 50(5). 673–677. 41 indexed citations

19.

Slaton, Joel W., Colin P. Dinney, Robert W. Veltri, et al.. (1997). Deoxyribonucleic Acid Ploidy Enhances the Cytological Prediction of Recurrent Transitional Cell Carcinoma of the Bladder. The Journal of Urology. 158(3 Pt 1). 806–811. 22 indexed citations

20.

Slaton, Joel W. & Barry D. Kahan. (1996). CASE REPORT-SIROLIMUS RESCUE THERAPY FOR REFRACTORY RENAL ALLOGRAFT REJECTION1. Transplantation. 61(6). 977–979. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact